These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 27717137

  • 1. Corrosion-Activated Chemotherapeutic Function of Nanoparticulate Platinum as a Cisplatin Resistance-Overcoming Prodrug with Limited Autophagy Induction.
    Cheng HJ, Wu TH, Chien CT, Tu HW, Cha TS, Lin SY.
    Small; 2016 Nov; 12(44):6124-6133. PubMed ID: 27717137
    [Abstract] [Full Text] [Related]

  • 2. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
    Ai F, Sun T, Xu Z, Wang Z, Kong W, To MW, Wang F, Zhu G.
    Dalton Trans; 2016 Aug 16; 45(33):13052-60. PubMed ID: 27430044
    [Abstract] [Full Text] [Related]

  • 3. Fighting against drug-resistant tumors by the inhibition of γ-glutamyl transferase with supramolecular platinum prodrug nano-assemblies.
    Wang L, Liu Z, He S, He S, Wang Y.
    J Mater Chem B; 2021 Jun 02; 9(22):4587-4595. PubMed ID: 34059856
    [Abstract] [Full Text] [Related]

  • 4. Multipronged Design of Light-Triggered Nanoparticles To Overcome Cisplatin Resistance for Efficient Ablation of Resistant Tumor.
    Li Y, Deng Y, Tian X, Ke H, Guo M, Zhu A, Yang T, Guo Z, Ge Z, Yang X, Chen H.
    ACS Nano; 2015 Oct 27; 9(10):9626-37. PubMed ID: 26365698
    [Abstract] [Full Text] [Related]

  • 5. A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance.
    Wang Z, Xu Z, Zhu G.
    Angew Chem Int Ed Engl; 2016 Dec 12; 55(50):15564-15568. PubMed ID: 27736029
    [Abstract] [Full Text] [Related]

  • 6. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
    Yang GG, Pan ZY, Zhang DY, Cao Q, Ji LN, Mao ZW.
    ACS Appl Mater Interfaces; 2020 Sep 30; 12(39):43444-43455. PubMed ID: 32883070
    [Abstract] [Full Text] [Related]

  • 7. Imidazole modified Pt(iv) prodrug-loaded multi-stage pH responsive nanoparticles to overcome cisplatin resistance.
    Kang X, Wang Y, Chen Z, Wu Y, Chen H, Yang X, Yu C.
    Chem Commun (Camb); 2020 Sep 28; 56(76):11271-11274. PubMed ID: 32830841
    [Abstract] [Full Text] [Related]

  • 8. Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment.
    Wang Z, Deng Z, Zhu G.
    Dalton Trans; 2019 Feb 19; 48(8):2536-2544. PubMed ID: 30633263
    [Abstract] [Full Text] [Related]

  • 9. Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo.
    Yu C, Ding B, Zhang X, Deng X, Deng K, Cheng Z, Xing B, Jin D, Ma P, Lin J.
    Biomaterials; 2018 Feb 19; 155():112-123. PubMed ID: 29175080
    [Abstract] [Full Text] [Related]

  • 10. Peptide-Based Autophagic Gene and Cisplatin Co-delivery Systems Enable Improved Chemotherapy Resistance.
    Lin YX, Wang Y, An HW, Qi B, Wang J, Wang L, Shi J, Mei L, Wang H.
    Nano Lett; 2019 May 08; 19(5):2968-2978. PubMed ID: 30924343
    [Abstract] [Full Text] [Related]

  • 11. Synergic highly effective photothermal-chemotherapy with platinum prodrug linked melanin-like nanoparticles.
    Zhang C, Zhao X, Guo H.
    Artif Cells Nanomed Biotechnol; 2018 May 08; 46(sup2):356-363. PubMed ID: 29607699
    [Abstract] [Full Text] [Related]

  • 12. Reduction-sensitive platinum (IV)-prodrug nano-sensitizer with an ultra-high drug loading for efficient chemo-radiotherapy of Pt-resistant cervical cancer in vivo.
    Luo K, Guo W, Yu Y, Xu S, Zhou M, Xiang K, Niu K, Zhu X, Zhu G, An Z, Yu Q, Gan Z.
    J Control Release; 2020 Oct 10; 326():25-37. PubMed ID: 32531414
    [Abstract] [Full Text] [Related]

  • 13. New Platinum(II) agent induces bimodal death of apoptosis and autophagy against A549 cancer cell.
    Wang FY, Huang KB, Feng HW, Chen ZF, Liu YN, Liang H.
    Free Radic Biol Med; 2018 Dec 10; 129():418-429. PubMed ID: 30266678
    [Abstract] [Full Text] [Related]

  • 14. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells.
    Cetraz M, Sen V, Schoch S, Streule K, Golubev V, Hartwig A, Köberle B.
    Arch Toxicol; 2017 Feb 10; 91(2):785-797. PubMed ID: 27307157
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer.
    Lu H, Tong W, Jiang M, Liu H, Meng C, Wang K, Mu X.
    ACS Nano; 2024 Aug 13; 18(32):21156-21170. PubMed ID: 39088743
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.